DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Combipatch (Estradiol / Norethindrone) - Breast Cyst - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Breast Cyst (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Combipatch (Estradiol / Norethindrone) where reactions include breast cyst. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Combipatch side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-30

Patient: female

Reactions: Breast Cyst, Breast Tenderness, Breast Mass

Drug(s) suspected as cause:
Combipatch



Possible Combipatch side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-25

Patient: female

Reactions: Breast Cyst, Breast Tenderness, Breast Mass

Drug(s) suspected as cause:
Combipatch



Possible Combipatch side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-20

Patient: female, weighing 95.2 kg (209.5 pounds)

Reactions: Osteoporosis, Perivascular Dermatitis, Radiation Skin Injury, Headache, Fall, Fibrocystic Breast Disease, Breast Cyst, Skin Lesion, Breast Cancer, Breast Pain, Breast Disorder, Post Herpetic Neuralgia, Breast Mass, Osteopenia, Rash, Breast Calcifications, Paraesthesia, Hyperlipidaemia, Burning Sensation, Breast Haemorrhage, Arthralgia, Nuclear Magnetic Resonance Imaging Abnormal, Breast Inflammation, Breast Fibrosis, Influenza Like Illness

Drug(s) suspected as cause:
Combipatch
    Dosage: 0.5 mg, unk
    Indication: Menopause
    Start date: 2001-01-24
    End date: 2005-01-03

Prempro
    Administration route: Oral
    Indication: Menopause
    Start date: 1998-01-01
    End date: 2000-12-01

Premarin
    Administration route: Oral
    Indication: Menopause
    Start date: 1995-01-01
    End date: 1997-12-01

Provera
    Administration route: Oral
    Indication: Menopause
    Start date: 1995-01-01
    End date: 1997-12-01

Other drugs received by patient: Lipitor; Atenolol

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017